Guru Inc. recalls Infla-650 Herbal Dietary Supplement, 700mg
The stated reason: Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.
Guru Inc. began a drug recall on June 26, 2024 whose reported distribution included Ohio. FDA
What the record shows
recalled Infla-650 Herbal Dietary Supplement, 700mg, packaged in pouches containing 60 capsules, Distributed by: Guru Inc., 4370 Lawrenceville Hwy NW, P.O. Box… beginning June 26, 2024, in a drug recall whose distribution included Ohio. FDA graded it Class II — use may cause temporary or medically reversible health consequences. The recall is listed as ongoing. FDA
Context
By the numbers
- Date of record: June 26, 2024 FDA
- Recall number: D-0666-2024 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Guru Inc. FDA
- Product: Infla-650 Herbal Dietary Supplement, 700mg, packaged in pouches containing 60 capsules, Distributed by: Guru Inc.… FDA
- Reason for recall: Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen… FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | D-0666-2024 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Guru Inc. |
| Product | Infla-650 Herbal Dietary Supplement, 700mg, packaged in pouches containing 60 capsules, Distributed by: Guru Inc., 4370 Lawrenceville Hwy NW, P.O. Box 2204, Lilburn, GA 30047-1100, USA. Ph.: 872 216 1566, http://www.dalayurevda.com, Made in India, UPC: 042535355019 |
| Reason for recall | Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | drug |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20240626 |
| Reported | 20241002 |
| Distribution | Retail: South Carolina, North Carolina, Ohio; Consumer level: Nationwide within USA |
| Firm location | Lilburn, GA, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.